Latest news with #KPJHealthcare
Barnama
07-07-2025
- Health
- Barnama
KPJ Healthcare Clinches 15 Awards At GHAPAC 2025, Reaffirms Regional Leadership
Chief Marketing Officer of KPJ Healthcare Berhad, Sherene Azli (third, left) together with Team KPJ at the GlobalHealth Asia-Pacific Summit, Conference and Awards 2025. (Credit: KPJ Healthcare) KUALA LUMPUR, July 7 (Bernama) -- KPJ Healthcare Berhad reaffirmed its position as a regional leader in patient-centred, tech-driven care by emerging as the most awarded healthcare group at the 2025 GlobalHealth Asia-Pacific (GHAPAC) Awards, held recently in Bangkok, Thailand. In a statement today, KPJ Healthcare announced it had clinched a total of 15 awards, reinforcing its standing as a regional leader in patient-centred, technology-driven care. KPJ Healthcare president and managing director Chin Keat Chyuan said the recognition was a testament to the dedication and teamwork spirit across the group's network. "Being recognised across such a wide range of specialties shows the depth of our clinical capabilities and our continuous efforts to improve. "Guided by our purpose of Care for Life, we remain focused on delivering world-class care that is powered by innovation and compassion," he said in the statement. Held alongside the GlobalHealth Asia-Pacific Summit and Conference, the GHAPAC Awards honoured excellence in clinical innovation, healthcare service delivery and medical technology across the region. Seven KPJ hospitals were recognised across various clinical disciplines, reinforcing the group's leadership in specialised care and service excellence. KPJ Tawakkal KL Specialist Hospital earned four major honours for Diagnostic Imaging Centre of the Year, Ear, Nose, and Throat (ENT) Service Provider of the Year, Urology Service Provider of the Year, and Brain and Spine Service Provider of the Year. Damansara Specialist Hospital 2 picked up three key honours: Minimal Invasive Cardiac Surgery of the Year, Smart Hospital of the Year, and Cardiology Service Provider of the Year.
Borneo Post
06-07-2025
- Health
- Borneo Post
KPJ Kuching completes 1,111th robotic-assisted knee replacement procedure
KPJ Kuching medical director Dr Mahadhir Alhady Sulaiman (third left), Dr Lee, KPJ Kuching general manager Nor Azlina Jemain and KPJ Healthcare Berhad regional chief executive officer of East Malaysia Dr Kenny take a group photo with representatives from Zimmer and Johnson & Johnson to celebrate the 1,111th procedure. KUCHING (July 6): KPJ Kuching Specialist Hospital has completed its 1,111th robotic-assisted Total Knee Replacement (TKR), marking a key milestone in the hospital's commitment to precision surgery and improved patient outcomes. The hospital in a statement on Saturday said this latest procedure reflects the hospital's sustained focus on clinical excellence and its leadership in robotic-assisted joint replacement within KPJ Healthcare. The achievement builds on its recent recognition as Orthopaedic Service Provider of the Year — Asia-Pacific 2025 at the GlobalHealth Asia-Pacific Awards, which acknowledged its innovation, surgical outcomes and patient care standards. The procedures are performed using the ROSA® Knee System by Zimmer Biomet and the VELYS™ Robotic-Assisted Solution by Johnson & Johnson. These systems enhance surgical accuracy, support faster recovery, and improve long-term mobility—particularly for patients with chronic knee pain or advanced osteoarthritis. KPJ Healthcare president and managing director Chin Keat Chyuan said the milestone at KPJ Kuching reflects the strength of the group's network-wide focus on quality, innovation, and subspecialty development. 'Under the KPJ Health System, we are advancing high-impact clinical programmes that deliver better outcomes for our patients. 'Guided by our purpose of Care for Life, we remain committed to expanding access to technology-driven, personalised care across our hospitals,' he said. Meanwhile, Consultant Orthopaedic Surgeon and pioneer of robotic knee surgery at KPJ Kuching Dr Lee Woo Guan said each knee represents a person regaining their ability to move confidently and live independently. 'Robotic technology like ROSA and VELYS has helped us personalise each procedure with greater precision and consistency, which directly translates into better outcomes and faster recovery for our patients,' he said. He added that the robotic programme has enabled KPJ Kuching to achieve lower complication rates, shorter hospital stays, and higher levels of patient satisfaction. 'More patients are now opting for robotic-assisted procedures as part of their care journey, particularly for improved mobility and long-term joint health,' he said. KPJ Healthcare continues to strengthen its investment in robotic technology, clinical leadership, and sub-specialty services as part of its transformation journey. These efforts align with the Group's strategy to integrate care delivery, education, and research, as well as to raise the overall standard of care across Malaysia. For more information, visit
Barnama
06-07-2025
- Health
- Barnama
KPJ Kuching Marks Milestone With 1,111th Robotic-assisted Knee Surgery
KUCHING, July 6 (Bernama) -- KPJ Kuching Specialist Hospital has successfully completed its 1,111th robotic-assisted total knee replacement (TKR), marking a significant milestone in precision orthopaedic surgery. In a statement today, the hospital said the achievement reflects its ongoing commitment to clinical excellence and its position as a leader in robotic-assisted joint replacement within the KPJ Healthcare network. "This milestone builds upon the hospital's recent recognition as the Orthopaedic Service Provider of the Year – Asia-Pacific 2025 at the GlobalHealth Asia-Pacific Awards, which acknowledged its innovation, surgical outcomes, and patient care standards," the statement read. The robotic-assisted procedures at KPJ Kuching are conducted using the ROSA® Knee System by Zimmer Biomet and the VELYS™ Robotic-Assisted Solution by Johnson & Johnson — both advanced technologies designed to enhance surgical accuracy and patient outcomes. 'These systems offer greater precision, faster recovery times, and improved long-term mobility, particularly for patients suffering from chronic knee pain or advanced osteoarthritis,' the hospital added. KPJ Kuching noted that its robotic surgery programme has led to lower complication rates, reduced hospital stays, and higher patient satisfaction, with a growing number of patients now choosing robotic-assisted procedures. 'KPJ Healthcare remains committed to investing in robotic technology, clinical leadership, and subspecialty services as part of its broader transformation agenda,' the statement added. -- BERNAMA
Yahoo
03-07-2025
- Business
- Yahoo
Will Weakness in KPJ Healthcare Berhad's (KLSE:KPJ) Stock Prove Temporary Given Strong Fundamentals?
It is hard to get excited after looking at KPJ Healthcare Berhad's (KLSE:KPJ) recent performance, when its stock has declined 4.8% over the past month. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. In this article, we decided to focus on KPJ Healthcare Berhad's ROE. ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company's success at turning shareholder investments into profits. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for KPJ Healthcare Berhad is: 13% = RM370m ÷ RM2.8b (Based on the trailing twelve months to March 2025). The 'return' is the amount earned after tax over the last twelve months. So, this means that for every MYR1 of its shareholder's investments, the company generates a profit of MYR0.13. Check out our latest analysis for KPJ Healthcare Berhad So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. To start with, KPJ Healthcare Berhad's ROE looks acceptable. Further, the company's ROE compares quite favorably to the industry average of 9.2%. This probably laid the ground for KPJ Healthcare Berhad's significant 25% net income growth seen over the past five years. We believe that there might also be other aspects that are positively influencing the company's earnings growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio. As a next step, we compared KPJ Healthcare Berhad's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 15%. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock's future looks promising or ominous. What is KPJ worth today? The intrinsic value infographic in our free research report helps visualize whether KPJ is currently mispriced by the market. The high three-year median payout ratio of 51% (implying that it keeps only 49% of profits) for KPJ Healthcare Berhad suggests that the company's growth wasn't really hampered despite it returning most of the earnings to its shareholders. Moreover, KPJ Healthcare Berhad is determined to keep sharing its profits with shareholders which we infer from its long history of paying a dividend for at least ten years. Based on the latest analysts' estimates, we found that the company's future payout ratio over the next three years is expected to hold steady at 51%. Accordingly, forecasts suggest that KPJ Healthcare Berhad's future ROE will be 15% which is again, similar to the current ROE. Overall, we are quite pleased with KPJ Healthcare Berhad's performance. Especially the high ROE, Which has contributed to the impressive growth seen in earnings. Despite the company reinvesting only a small portion of its profits, it still has managed to grow its earnings so that is appreciable. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $384.84 · 0.2% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The Star
26-06-2025
- Health
- The Star
KPJ Healthcare aims 70% business volume from age-related, NCD cases this year
KUALA LUMPUR: KPJ Healthcare Bhd expects age-related and non-communicable disease (NCD) cases to contribute about 70 per cent of its business volume this year. Its president and managing director Chin Keat Chyuan said that currently, about 15 per cent of Malaysia's general population is aged 60 and above. "Age comes with many associated diseases like NCDs, the three highs that we always talk about, namely high blood sugar, high cholesterol, and high blood pressure. "And all these lead to many potential issues, including oncology problems such as cancer, which is a major concern facing Malaysians,' he said in a press conference after KPJ Healthcare's 32nd annual general meeting and extraordinary general meeting, here today. Chin said these challenges represent opportunities for private healthcare providers to better serve the Malaysian population, including addressing international healthcare risk factors. "This represents a huge opportunity, and in 2025, KPJ will continue to expand our capacity, both in terms of the number of clinicians we have and the services we offer,' he said. He added that NCDs such as heart and lung diseases, neurological conditions, strokes, cancer, and orthopaedic issues provide KPJ with opportunities to serve patients using advanced surgical and medical solutions. Commenting on medical tourism, Chin said KPJ is also targeting patients from Indonesia. "I am also targeting the potential 20 per cent of Indonesia's 270 million population, that is 54 million people, who are currently travelling outside Indonesia, to seek treatment in countries such as Singapore, Malaysia, Thailand, and Vietnam. "And according to data from the Malaysia Healthcare Travel Council, more than 40 per cent of those Indonesian patients are coming to Malaysia, which is contributing significantly to our health tourism industry,' he said. He said that this is an immediate business opportunity, especially as the group expands its workforce and increases the number of beds in its hospitals. "We are (also) optimising all the assets we have, such as magnetic resonance imaging machines, computed tomography scanners, and other technologies we have invested in,' he added. Also present at the press conference were KPJ Healthcare chairman Tan Sri Dr Ismail Bakar and chief financial officer Mohd Khairul Izzad Mohammed Shamsudin. - Bernama
